Published in Blood Weekly, November 17th, 2005
According to the current results from the endogenous (blood-borne) infectivity study cosponsored by PRDT, its partner MacoPharma, and ProMetic, none of the 100 lab animals (hamsters) injected with leukoreduced scrapie infected whole blood, previously filtered through devices containing the PRDT resin, developed signs of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.